bifendate and its Impurities
Bifendate is used to treat liver diseases and it's bioactivity involves decreasing alanine aminotransferase and aspartate aminotransferase secreted by hepatocytes in chronic hepatitis B and attenuating hepatic steatosis. Reference standards of Bifendate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
 
	
			                                  ![4,10-Dimethoxy-[1,3]dioxolo[4',5':3,4]benzo[1,2-c] PA 02 2601002](https://www.pharmaffiliates.com/pimages/PA022601002.jpg) 
																				4,10-Dimethoxy-[1,3]dioxolo[4',5':3,4]benzo[1,2-c][1,3]dioxolo[4',5':5,6]benzo[1,2-e]oxepin-6(8H)-one
4,10-Dimethoxy-[1,3]dioxolo[4',5':3,4]benzo[1,2-c][1,3]dioxolo[4',5':5,6]benzo[1,2-e]oxepin-6(8H)-one
- Catalogue No.:PA 02 2601002 
- CAS : - 118159-47-0
- Molecular Formula : C18H14O8 
- Molecular Weight : 358.3 
 
	
			                                   
																				(7,7'-Dimethoxy-5'-(methoxycarbonyl)-[4,4'-bibenzo[d][1,3]dioxol]-5-yl)methyl 5'-(hydroxymethyl)-7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5-carboxylate
(7,7'-Dimethoxy-5'-(methoxycarbonyl)-[4,4'-bibenzo[d][1,3]dioxol]-5-yl)methyl 5'-(hydroxymethyl)-7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5-carboxylate
- Catalogue No.:PA 02 2601003 
- CAS : - NA
- Molecular Formula : C37H32O17 
- Molecular Weight : 748.65 

 
																				 
																				 
																				![5'-(Hydroxymethyl)-7,7'-dimethoxy-[4,4'-bibenzo[d] PA 02 2601001](https://www.pharmaffiliates.com/pimages/PA022601001.jpg) 
																				 
 
 
 
